Skip to main content
Top
Published in: Pediatric Radiology 12/2014

01-12-2014 | Minisymposium

Scoring of chest CT in children with cystic fibrosis: state of the art

Authors: Alistair D. Calder, Andrew Bush, Alan S. Brody, Catherine M. Owens

Published in: Pediatric Radiology | Issue 12/2014

Login to get access

Abstract

Chest CT has been proposed as a surrogate outcome measure in the evaluation of cystic fibrosis lung disease. Quantitative evaluation of chest CT findings requires application of a scoring system to derive numerical values. Several scoring systems are in use. These mostly rely on a subjective judgement of the severity and extent of various features of cystic fibrosis lung disease, including bronchiectasis, bronchial wall thickening, mucous plugging and air-trapping. Scores can subsequently be added to produce a total score. The precision or reproducibility of scoring systems has been assessed but with heterogeneous statistical approaches. Total scores appear to have high levels of reproducibility, but this might mask poorer levels of agreement for individual observations and component scores. It can also be questioned whether total scores are biologically meaningful, as compared to assessments of individual features. Various studies suggest that CT scores give an accurate indicator of the severity of disease, and CT scores might be the best predictors of long-term outcome, but data in this area are limited. CT scores are more sensitive than traditional lung-function indices such as FEV; however the lung clearance index, by multiple breath washout, appears to offer comparable sensitivity to CT. It is not clear whether CT scores are adequately responsive to changes in disease severity in the short to medium term; this is a challenge to the use of CT as a surrogate outcome measure for clinical trials of therapies specific to cystic fibrosis. Cystic fibrosis scoring would benefit from greater levels of standardisation in terms of CT techniques, scoring system, training of observers and measures of reproducibility. Automated approaches to quantifying CT parameters might also offer improved precision. The benefits of chest CT must be weighed against the principal drawback of radiation exposure. The case for more widespread use of chest CT would be strengthened if precision of CT scoring were improved.
Literature
1.
go back to reference Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: Scoring system with thin-section CT. Radiology 179:783–788PubMedCrossRef Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: Scoring system with thin-section CT. Radiology 179:783–788PubMedCrossRef
2.
go back to reference Brody AS, Klein JS, Molina PL et al (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145:32–38PubMedCrossRef Brody AS, Klein JS, Molina PL et al (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145:32–38PubMedCrossRef
3.
go back to reference Stick SM, Brennan S, Murray C et al (2009) Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155:623–628PubMedCrossRef Stick SM, Brennan S, Murray C et al (2009) Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155:623–628PubMedCrossRef
4.
go back to reference Loeve M, van Hal PT, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882PubMedCrossRef Loeve M, van Hal PT, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882PubMedCrossRef
5.
go back to reference Westgard JO, Carey RN, Wold S (1974) Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 20:825–833PubMed Westgard JO, Carey RN, Wold S (1974) Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 20:825–833PubMed
6.
go back to reference Ludbrook J (2002) Statistical techniques for comparing measurers and methods of measurement: A critical review. Clin Exp Pharmacol Physiol 29:527–536PubMedCrossRef Ludbrook J (2002) Statistical techniques for comparing measurers and methods of measurement: A critical review. Clin Exp Pharmacol Physiol 29:527–536PubMedCrossRef
7.
go back to reference Davis SD, Fordham LA, Brody A et al (2007) Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175:943–950PubMedCrossRef Davis SD, Fordham LA, Brody A et al (2007) Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175:943–950PubMedCrossRef
8.
go back to reference Owens CM, Aurora P, Stanojevic S et al (2011) London cystic fibrosis collaboration. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:481–488PubMedCrossRef Owens CM, Aurora P, Stanojevic S et al (2011) London cystic fibrosis collaboration. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:481–488PubMedCrossRef
9.
go back to reference Nasr SZ, Kuhns LR, Brown RW et al (2001) Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 31:377–382PubMedCrossRef Nasr SZ, Kuhns LR, Brown RW et al (2001) Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 31:377–382PubMedCrossRef
10.
go back to reference Nasr SZ, Gordon D, Sakmar E et al (2006) High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 41:1129–1137PubMedCrossRef Nasr SZ, Gordon D, Sakmar E et al (2006) High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 41:1129–1137PubMedCrossRef
11.
go back to reference Brody AS, Kosorok MR, Li Z et al (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21PubMedCrossRef Brody AS, Kosorok MR, Li Z et al (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21PubMedCrossRef
12.
go back to reference De Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439PubMedCrossRef De Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439PubMedCrossRef
13.
go back to reference Loeve M, Krestin GP, Rosenfeld M et al (2012) Chest computed tomography: A validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857PubMedCrossRef Loeve M, Krestin GP, Rosenfeld M et al (2012) Chest computed tomography: A validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857PubMedCrossRef
14.
go back to reference De Jong PA, Tiddens HA (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342PubMedCrossRef De Jong PA, Tiddens HA (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342PubMedCrossRef
15.
go back to reference Brenner H, Kliebsch U (1996) Dependence of weighted kappa coefficients on the number of categories. Epidemiology 7:199–202PubMedCrossRef Brenner H, Kliebsch U (1996) Dependence of weighted kappa coefficients on the number of categories. Epidemiology 7:199–202PubMedCrossRef
16.
go back to reference Gwet KL (2012) Handbook of inter-rater reliability, 3rd edn. Advanced Analytics, Gaithersburg Gwet KL (2012) Handbook of inter-rater reliability, 3rd edn. Advanced Analytics, Gaithersburg
17.
go back to reference Long FR, Williams RS, Castile R (2004) Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 144:154–161PubMedCrossRef Long FR, Williams RS, Castile R (2004) Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 144:154–161PubMedCrossRef
18.
go back to reference De Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85PubMedCentralPubMedCrossRef De Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85PubMedCentralPubMedCrossRef
19.
go back to reference Tepper LA, Utens E, Caudri (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 42:371–379PubMedCrossRef Tepper LA, Utens E, Caudri (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 42:371–379PubMedCrossRef
20.
go back to reference Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317PubMedCrossRef Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317PubMedCrossRef
21.
go back to reference Gupta K, Gupta J, Singh S (2010) Surrogate endpoints: How reliable are they? J Clin Res Best Pract 8:1–6 Gupta K, Gupta J, Singh S (2010) Surrogate endpoints: How reliable are they? J Clin Res Best Pract 8:1–6
23.
24.
go back to reference De Jong PA, Nakano Y, Lequin MH et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97PubMedCrossRef De Jong PA, Nakano Y, Lequin MH et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97PubMedCrossRef
25.
go back to reference Demirkazik FB, Ariyürek OM, Ozçelik U et al (2001) High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59PubMedCrossRef Demirkazik FB, Ariyürek OM, Ozçelik U et al (2001) High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59PubMedCrossRef
26.
go back to reference Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A (2006) Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:129–134CrossRef Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A (2006) Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:129–134CrossRef
27.
go back to reference Ellemunter H, Fuchs SI, Unsinn KM et al (2010) Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:1834–1842PubMedCrossRef Ellemunter H, Fuchs SI, Unsinn KM et al (2010) Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:1834–1842PubMedCrossRef
28.
go back to reference Sanders DB, Li Z, Brody AS, Farrell PM (2011) Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 184:816–821PubMedCentralPubMedCrossRef Sanders DB, Li Z, Brody AS, Farrell PM (2011) Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 184:816–821PubMedCentralPubMedCrossRef
29.
go back to reference Simanovsky N, Cohen-Cymberknoh M, Shoseyov D et al (2013) Differences in the pattern of structural abnormalities on CT in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest 144:208–241PubMedCrossRef Simanovsky N, Cohen-Cymberknoh M, Shoseyov D et al (2013) Differences in the pattern of structural abnormalities on CT in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest 144:208–241PubMedCrossRef
30.
go back to reference Sly PD, Brennan S, Gangell C et al (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152PubMedCrossRef Sly PD, Brennan S, Gangell C et al (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152PubMedCrossRef
31.
go back to reference Loeve M, Hop WC, de Bruijne M et al (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185:1096–1103PubMedCrossRef Loeve M, Hop WC, de Bruijne M et al (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185:1096–1103PubMedCrossRef
32.
go back to reference Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172:1128–1132PubMedCrossRef Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172:1128–1132PubMedCrossRef
33.
go back to reference Loeve M, Gerbrands K, Hop WC et al (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140:178–185PubMedCrossRef Loeve M, Gerbrands K, Hop WC et al (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140:178–185PubMedCrossRef
34.
go back to reference Byrnes CA, Vidmar S, Cheney JL et al (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 68:643–651PubMedCentralPubMedCrossRef Byrnes CA, Vidmar S, Cheney JL et al (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 68:643–651PubMedCentralPubMedCrossRef
35.
go back to reference Shah RM, Sexauer W, Ostrum BJ et al (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 169:375–380PubMedCrossRef Shah RM, Sexauer W, Ostrum BJ et al (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 169:375–380PubMedCrossRef
36.
go back to reference Brody AS, Molina PL, Klein JS et al (1999) High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 29:731–735PubMedCrossRef Brody AS, Molina PL, Klein JS et al (1999) High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 29:731–735PubMedCrossRef
37.
go back to reference Horsley AR, Davies JC, Gray RD et al (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 638:532–539CrossRef Horsley AR, Davies JC, Gray RD et al (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 638:532–539CrossRef
38.
go back to reference Moss RB, Rodman D, Spencer LT et al (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125:509–521PubMedCrossRef Moss RB, Rodman D, Spencer LT et al (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125:509–521PubMedCrossRef
39.
go back to reference Robinson TE, Goris ML, Zhu HJ et al (2005) Dornase Alfa reduces air trapping in children with mild cystic fibrosis lung disease: A quantitative analysis. Chest 128:2327–2335PubMedCrossRef Robinson TE, Goris ML, Zhu HJ et al (2005) Dornase Alfa reduces air trapping in children with mild cystic fibrosis lung disease: A quantitative analysis. Chest 128:2327–2335PubMedCrossRef
40.
go back to reference Robinson TE, Leung AN, Northway WH et al (2003) Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 168:588–593PubMedCrossRef Robinson TE, Leung AN, Northway WH et al (2003) Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 168:588–593PubMedCrossRef
41.
go back to reference Nasr SZ, Sakmar E, Christodoulou E et al (2010) The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 45:440–449PubMed Nasr SZ, Sakmar E, Christodoulou E et al (2010) The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 45:440–449PubMed
42.
go back to reference Beydon N, Davis SD, Lombardi E et al (2007) An official American thoracic society/European respiratory society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345PubMedCrossRef Beydon N, Davis SD, Lombardi E et al (2007) An official American thoracic society/European respiratory society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345PubMedCrossRef
43.
go back to reference Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161PubMedCrossRef Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161PubMedCrossRef
44.
go back to reference Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef
45.
go back to reference Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRef Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRef
46.
go back to reference Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522PubMedCrossRef Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522PubMedCrossRef
47.
go back to reference Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968PubMedCrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968PubMedCrossRef
48.
go back to reference Montaudon M, Berger P, Cangini-Sacher A (2007) Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 242:573–581PubMedCrossRef Montaudon M, Berger P, Cangini-Sacher A (2007) Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 242:573–581PubMedCrossRef
49.
go back to reference Tanaka N, Matsumoto T, Miura G et al (2003) Air trapping at CT: High prevalence in asymptomatic subjects with normal pulmonary function. Radiology 227:776–785PubMedCrossRef Tanaka N, Matsumoto T, Miura G et al (2003) Air trapping at CT: High prevalence in asymptomatic subjects with normal pulmonary function. Radiology 227:776–785PubMedCrossRef
50.
go back to reference Matsuoka S, Uchiyama K, Shima H et al (2003) Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 180:513–518PubMedCrossRef Matsuoka S, Uchiyama K, Shima H et al (2003) Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 180:513–518PubMedCrossRef
51.
go back to reference Mott LS, Park J, Gangell CL et al (2013) Distribution of early structural lung age changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 163:243–248PubMedCrossRef Mott LS, Park J, Gangell CL et al (2013) Distribution of early structural lung age changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 163:243–248PubMedCrossRef
52.
go back to reference Kapur N, Masel JP, Watson D et al (2011) Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: Need to redefine bronchial dilatation. Chest 139:1445–1150PubMedCrossRef Kapur N, Masel JP, Watson D et al (2011) Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: Need to redefine bronchial dilatation. Chest 139:1445–1150PubMedCrossRef
53.
go back to reference Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: Glossary of terms for thoracic imaging. Radiology 246:697–722PubMedCrossRef Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: Glossary of terms for thoracic imaging. Radiology 246:697–722PubMedCrossRef
54.
go back to reference Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516PubMedCrossRef Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516PubMedCrossRef
55.
go back to reference Robinson TE (2007) Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4:310–315PubMedCrossRef Robinson TE (2007) Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4:310–315PubMedCrossRef
56.
go back to reference Mumcuoglu EU, Prescott J, Baker BN et al (2009) Image analysis for cystic fibrosis: Automatic lung airway wall and vessel measurement on CT images. Conf Proc IEEE Eng Med Biol Soc 2009:3545–3548PubMed Mumcuoglu EU, Prescott J, Baker BN et al (2009) Image analysis for cystic fibrosis: Automatic lung airway wall and vessel measurement on CT images. Conf Proc IEEE Eng Med Biol Soc 2009:3545–3548PubMed
57.
go back to reference Goris ML, Zhu HJ, Blankenberg F (2003) An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123:1655–1663PubMedCrossRef Goris ML, Zhu HJ, Blankenberg F (2003) An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123:1655–1663PubMedCrossRef
58.
go back to reference Mott LS, Graniel KG, Park J et al (2013) Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 144:1193–1198PubMedCrossRef Mott LS, Graniel KG, Park J et al (2013) Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 144:1193–1198PubMedCrossRef
59.
go back to reference Tiddens HA (2006) Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7:202–208PubMedCrossRef Tiddens HA (2006) Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7:202–208PubMedCrossRef
60.
go back to reference O’Connell OJ, McWilliams S, McGarrigle A et al (2012) Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades. Chest 141:1575–1583PubMedCrossRef O’Connell OJ, McWilliams S, McGarrigle A et al (2012) Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades. Chest 141:1575–1583PubMedCrossRef
Metadata
Title
Scoring of chest CT in children with cystic fibrosis: state of the art
Authors
Alistair D. Calder
Andrew Bush
Alan S. Brody
Catherine M. Owens
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 12/2014
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-013-2867-y

Other articles of this Issue 12/2014

Pediatric Radiology 12/2014 Go to the issue